Targeted Complement Inhibition Protects Vascularized Composite Allografts From Acute Graft Injury and Prolongs Graft Survival When Combined With Subtherapeutic Cyclosporine A Therapy.
about
Targeted Complement Inhibition Protects Vascularized Composite Allografts From Acute Graft Injury and Prolongs Graft Survival When Combined With Subtherapeutic Cyclosporine A Therapy.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh-hant
name
Targeted Complement Inhibition ...... peutic Cyclosporine A Therapy.
@en
Targeted Complement Inhibition ...... peutic Cyclosporine A Therapy.
@nl
type
label
Targeted Complement Inhibition ...... peutic Cyclosporine A Therapy.
@en
Targeted Complement Inhibition ...... peutic Cyclosporine A Therapy.
@nl
prefLabel
Targeted Complement Inhibition ...... peutic Cyclosporine A Therapy.
@en
Targeted Complement Inhibition ...... peutic Cyclosporine A Therapy.
@nl
P2093
P2860
P1433
P1476
Targeted Complement Inhibition ...... apeutic Cyclosporine A Therapy
@en
P2093
Carl Atkinson
Chrystal M Paulos
Stephen Tomlinson
P2860
P304
P356
10.1097/TP.0000000000001625
P577
2017-04-01T00:00:00Z